- Editor's PickNicole Sinclair•7 hours ago
When it comes to hot-button political topics, soaring drug prices are at the top of the list. Companies from Mylan (MYL) to Valeant (VRX) have come under fire for soaring prices, and Tom Coburn, former Republican Senator from Oklahoma, says more medical innovation is necessary to keep this from happening. “There are a lot of products that aren’t available to American citizens because of our regulatory environment,” Coburn said.
- Investopedia•8 hours ago
Investors can derive great value from humility. By keeping the adage "all I know is that I know nothing" in mind, they can invest more effectively.
- Barrons.com•2 days ago
After a decade of working with family offices of all sizes, types, and means, Ned Dane, head of the OppenheimerFunds’ Private Client Group, says that in the end their goals are all the same: to generate income for families for hundreds of years. One long-term investment that Dane offers his clients is catastrophe bonds, which are a fixed-income form of reinsurance, traditionally the way the insurance industry spreads its bets to other insurance companies.
Valeant Pharmaceuticals International, Inc. (VRX)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||27.73 x 3000|
|Ask||27.79 x 100|
|Day's Range||26.46 - 27.84|
|52wk Range||18.55 - 206.51|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-9.44|
|Avg Vol (3m)||25,911,271|
|Dividend & Yield||0.00 (0.00%)|